Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04036461
Title A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN

Facility Status City State Zip Country Details
Local Institution - 107 La Jolla California 92093 United States Details
Local Institution - 105 Sarasota Florida 34232 United States Details
Local Institution - 103 Buffalo New York 14263 United States Details
Local Institution - 106 New York New York 10029 United States Details
Local Institution - 101 Portland Oregon 97239 United States Details
Local Institution - 104 Dallas Texas 75390 United States Details
Local Institution - 102 Seattle Washington 98104 United States Details
Local Institution - 202 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 201 Montreal Quebec H1T 2M4 Canada Details
Institut Paoli Calmettes Marseille Cedex 9 13273 France Details
CHU Montpellier - Hôpital Saint Eloi Montpellier CEDEX 5 34295 France Details
Hopital Saint Antoine Paris 75571 France Details
Local Institution - 305 Pierre Bénite 69495 France Details
Local Institution - 501 Bologna 40138 Italy Details
Local Institution - 405 Barcelona 08036 Spain Details
Local Institution - 401 Madrid 28041 Spain Details
Local Institution - 0505 Malaga 29010 Spain Details
Local Institution - 402 Salamanca 37007 Spain Details
Local Institution - 404 Sevillla 41013 Spain Details
Local Institution - 403 Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field